Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.
The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.
The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.
India’s Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.
As per NOVONOUS estimates, pharmaceuticals manufacturing industry in India is expected to grow at a CAGR of 19.76% till 2020. Despite slowing growth in developed markets, players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.
Medical devices manufacturing industry in India is expected to grow at a CAGR of 15% till 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.
Indian medical transcription Industry is expected to grow at a CAGR of 4.16% till 2020 found this study. The Pharma service predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others.
Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% till 2020.
On the other hand, Pharmaceuticals packaging industry in India is expected to grow at a CAGR of 5.46% till 2020.
NOVONOUS estimates that pharmaceuticals retail industry in India will grow at a CAGR of 5% in the next 5 years, which will be mainly driven by increased penetration of organized Pharma retail chains like Apollo Pharmacy, MedPlus etc.
The report also has detailed company profiles including their position in pharmaceuticals industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for sixteen key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy’s Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited, IPCA Laboratories Limited, Becton Dickinson & Company Limited, Poly Medicure Limited, Novartis India Limited, Apollo Pharmacy, MedPlus Health Services Pvt. Ltd. and National Institute of Pharmaceutical Education and Research (NIPER).
Scope of Pharmaceuticals Industry in India 2015 - 2020 report: - This report provides a detailed view of Indian pharmaceuticals market with current available capacity and options. - This report identifies the need for focusing on pharmaceuticals sector in India. - This report provides detailed information on growth forecasts for overall pharmaceuticals industry in India up to 2020. - This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020. - This report provides detailed information on growth forecasts for pharma services industry in India up to 2020. - This report provides detailed information on growth forecasts for pharmaceuticals packaging industry in India up to 2020. - This report provides detailed information on growth forecasts for pharmaceuticals retail industry in India up to 2020. - The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India. - This study also identifies policies related to pharmaceuticals market in India for various sectors. - The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging, pharmaceuticals retail, and pharmaceuticals R&D industry in India. - The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India. - The report identifies top countries exporting pharmaceuticals products and medical devices to India. - The report identifies top countries importing pharmaceuticals products and medical devices from India. - This report has detailed profiles 16 key players in Indian pharmaceuticals market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis. - This report covers in details the competitive landscape in Indian pharmaceuticals market. - This report identifies key industry bodies and associations and their role in Indian pharmaceuticals market. - This report identifies key government bodies and their role in Indian pharmaceuticals market. - This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals market. - This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India. - This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India. - This report provides future trends and opportunities for pharmaceuticals market in India. - This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.
Our reports have been used by over 10K customers, including:
Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Drugs In Development, 2021 Summary According to the recently published report ’Neuropeptide Y Receptor Type 2 - Drugs In Development, 2021’; Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) pipeline Target constitutes close to 5...
249 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...
43 pages •
By CCM Information Science & Technology Co., Ltd
• Jun 2021
If you subscribe annually, you can get a better price Vitamins China E-News provides you with real-time intelligence on China’s vitamins market. It is a monthly published newsletter, which can be downloaded in PDF format. The subscription period is yearly, grants the subscriber 12 issues in total. China...
What’s Ahead for the Pharmaceutical Industry?--Emerging Opportunities and Growth Strategies for Suppliers The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses: Organization...
This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the European life sciences and pharma industries in Q1 2021. In the evolving COVID-19 scenario, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
479 pages •
By Global Industry Analysts
• May 2021
Global Collagen Peptides Market to Reach $822.9 Million by 2027
Amid the COVID-19 crisis, the global market for Collagen Peptides estimated at US$564.4 Million in the year 2020, is projected to reach a revised size of US$822.9 Million by 2027, growing at a CAGR of 5.5% over the analysis...
120 pages •
By Infiniti Research Limited
• May 2021
Global Microbiomes Market 2021-2025 The analyst has been monitoring the microbiomes market and it is poised to grow by $ 713.01 million during 2021-2025, progressing at a CAGR of over 24% during the forecast period. Our report on microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers,...